SUTAB is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Braintree Laboratories, Inc.. The primary component is Sodium Sulfate; Magnesium Sulfate Anhydrous; Potassium Chloride.
Product ID | 52268-201_b48ca5eb-f031-b60b-e053-2a95a90a5ee2 |
NDC | 52268-201 |
Product Type | Human Prescription Drug |
Proprietary Name | SUTAB |
Generic Name | Sodium Sulfate, Magnesium Sulfate, And Potassium Chloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2020-11-10 |
Marketing Category | NDA / NDA |
Application Number | NDA213135 |
Labeler Name | Braintree Laboratories, Inc. |
Substance Name | SODIUM SULFATE; MAGNESIUM SULFATE ANHYDROUS; POTASSIUM CHLORIDE |
Active Ingredient Strength | 18 g/1; g/1; g/1 |
Pharm Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-11-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SUTAB 88656899 not registered Live/Pending |
Sebela BT Holdings, Inc. 2019-10-16 |
SUTAB 88656848 not registered Live/Pending |
Sebela BT Holdings, Inc. 2019-10-16 |